Duloxetine versus other anti-depressive agents for depression-Reference-Cited by-同舟云学术

Duloxetine versus other anti-depressive agents for depression

Published:2012-10-17 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Cipriani Andrea¹,Koesters Markus²,Furukawa Toshi A³,Nosè Michela⁴,Purgato Marianna¹,Omori Ichiro M⁵,Trespidi Carlotta¹,Barbui Corrado¹

Affiliation:

1. University of Verona; Department of Public Health and Community Medicine, Section of Psychiatry; Policlinico "G.B.Rossi" Piazzale L.A. Scuro, 10 Verona Italy 37134

2. Ulm University; Department of Psychiatry ll; Ludwig-Heilmeyer-Str. 2 Guenzburg Germany D-89312

3. Kyoto University Graduate School of Medicine / School of Public Health; Department of Health Promotion and Human Behavior; Yoshida Konoe-cho, Sakyo-ku, Kyoto Japan 601-8501

4. University of Verona; Department of Medicine and Public Health, Section of Psychiatry; Policlinico "G.B.Rossi" Pzz.le L.A. Scuro, 10 Verona Italy 37134

5. Toyokawa City Hospital; Department of Psychiatry; Koumei 1-19 Toyokawa Aichi Japan 442-8561

Publisher

Wiley

Subject

Pharmacology (medical)

Reference139 articles.

1. Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study;Cutler;Journal of Clinical Psychiatry,2009

2. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial;Detke;Europen Neuropsychopharmacology,2004

3. Eli Lilly Trial Duloxetine versus placebo and paroxetine in the treatment of major depression [Trial 4298a, HMAYAa] www.clinicalstudyresults.org/documents/company-study_887_0.pdf [accessed 5 October 2007, archived data on file]

4. Demitrack MA Goldstein DJ Mallinckrodt C Lu Y Efficacy and safety of duloxetine treatment in major depression 154th Annual Meeting of American Psychiatric Association

5. Eli Lilly Duloxetine versus placebo in the treatment of major depression [Trial 3327a, HAMAQ A] http://www.clinicalstudyresults.org/documents/company-study_137_0.pdf [accessed 5 October 2007, archived data on file]

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different dosage regimens of zuranolone in the treatment of major depressive disorder: A meta-analysis of randomized controlled trials;Journal of Affective Disorders;2024-06

2. From Evidence to Practice: A Comprehensive Analysis of Side Effects in Synthetic Anti-Depressant Therapy;Current Drug Safety;2024-04-25

3. VALVULAR HEART DISEASE MANAGED WITH AYURVEDA TREATMENT - A CASE STUDY;International Ayurvedic Medical Journal;2023-12-17

4. Antidepressant duloxetine hydrochloride protects against ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation;Biomedicine & Pharmacotherapy;2023-12

5. Is antidepressant use a concern for patients with COPD?;Thorax;2023-09-15